Please assess the completion status of the following clinical trial:

Trial Title: GW823093C For The Treatment Of Type 2 Diabetes Mellitus

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion criteria:~* Type 2 diabetes mellitus.~* Managed by diet therapy or receiving treatment with oral anti-diabetic monotherapy (excluding TZD (Thiazolidinediones))~Exclusion criteria:~* Patients who have metabolic disease judged by investigator as a clinically significance~* Serious cardiovascular disease or serious hepatic disease

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 74 Years
- Healthy Volunteers: f

Study Arms:
- GW823093C A (Type: PLACEBO_COMPARATOR): A=45 mg
- GW823093C B (Type: PLACEBO_COMPARATOR): B=30 mg
- GW823093C C (Type: PLACEBO_COMPARATOR): C=15 mg

Based on this trial design, predict the completion outcome and termination type (if applicable).